Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review
Background Pharmaceutical companies spent $57.5 billion on pharmaceutical promotion in the United States in 2004. The industry claims that promotion provides scientific and educational information to physicians. While some evidence indicates that promotion may adversely influence prescribing, physi...
محفوظ في:
المؤلفون الرئيسيون: | Spurling, Geoffrey K., Mansfield, Peter R., Montgomery, Brett D., Lexchin, Joel, Doust, Jenny, Othman, Noordin, Vitry, Agnes I. |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
Public Library of Science
2010
|
الموضوعات: | |
الوصول للمادة أونلاين: | http://irep.iium.edu.my/346/1/journal.pmed.1000352.pdf http://irep.iium.edu.my/346/ http://dx.doi.org/10.1371/journal.pmed.1000352 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Quality of pharmaceutical advertisements in medical journals: a systematic review
بواسطة: Othman, Noordin, وآخرون
منشور في: (2009) -
Pharmaceutical promotion : the theoretical framework of regulation.
بواسطة: Othman, Noordin, وآخرون
منشور في: (2011) -
The challenge of pharmaceutical promotion regulation in Malaysia.
بواسطة: Othman, Noordin, وآخرون
منشور في: (2011) -
Prescribing of Strong Opioid Analgesics by UK Primary Care Physicians from 2000 to 2010
بواسطة: Zin, Che Suraya, وآخرون
منشور في: (2012) -
Prescribing of strong opioid analgesics by UK primary care physicians from 2000 to 2010
بواسطة: Zin, Che Suraya, وآخرون
منشور في: (2012)